545. Targeting negative and cognitive symptoms in schizophrenia: discussion of novel preclinical and clinical findings with evenamide
Clinical findings from phase 2/3 trials with evenamide are interpreted in light of the results obtained with MAM model, and new analyses on the effect of evenamide on negative symptoms are presented to present new analyses on the effect of evenamide on negative symptoms.